KINGDON CAPITAL MANAGEMENT, L.L.C. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,006,000
-75.1%
56,200
-80.5%
0.07%
-70.3%
Q1 2017$4,037,000
-39.6%
288,392
-31.1%
0.22%
-31.3%
Q4 2016$6,679,000
-53.0%
418,732
-51.0%
0.32%
-50.5%
Q3 2016$14,222,000
+34.6%
854,656
-9.5%
0.65%
+12.0%
Q2 2016$10,570,000
+172.1%
944,568
+103.3%
0.58%
+172.0%
Q1 2016$3,884,000
-55.4%
464,568
-50.3%
0.21%
-49.4%
Q4 2015$8,701,000
-65.6%
934,568
-58.3%
0.42%
-65.3%
Q3 2015$25,304,000
-6.9%
2,243,267
+4.7%
1.22%
+14.8%
Q2 2015$27,180,000
-12.3%
2,141,835
-35.7%
1.06%
-19.1%
Q1 2015$30,989,000
-12.1%
3,332,189
+35.4%
1.31%
-14.2%
Q4 2014$35,246,000
+61.3%
2,461,305
+16.9%
1.53%
+56.0%
Q3 2014$21,852,000
-36.9%
2,105,180
-1.6%
0.98%
-26.1%
Q2 2014$34,632,000
+11.4%
2,140,400
+11.8%
1.33%
-16.4%
Q1 2014$31,090,000
+11.9%
1,913,942
-14.5%
1.59%
+24.8%
Q4 2013$27,780,000
+103.1%
2,239,350
+79.3%
1.27%
+89.3%
Q3 2013$13,681,000
+162.6%
1,248,650
+93.3%
0.67%
+117.5%
Q2 2013$5,210,000645,8500.31%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders